IHT Wealth Management LLC Invests $266,000 in Solventum Co. (NYSE:SOLV)

IHT Wealth Management LLC bought a new position in shares of Solventum Co. (NYSE:SOLV) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,873 shares of the company’s stock, valued at approximately $266,000.

A number of other institutional investors and hedge funds have also modified their holdings of SOLV. Deseret Mutual Benefit Administrators purchased a new stake in shares of Solventum during the second quarter worth about $25,000. Hollencrest Capital Management purchased a new stake in shares of Solventum during the second quarter worth about $25,000. Richard W. Paul & Associates LLC purchased a new stake in shares of Solventum during the second quarter worth about $26,000. Family Firm Inc. purchased a new stake in shares of Solventum during the second quarter worth about $26,000. Finally, Copeland Capital Management LLC purchased a new stake in shares of Solventum during the third quarter worth about $26,000.

Solventum Price Performance

Shares of SOLV stock opened at $70.64 on Tuesday. The firm’s 50 day moving average price is $70.71 and its 200-day moving average price is $62.96. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Stifel Nicolaus initiated coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price for the company. Morgan Stanley upped their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Piper Sandler upped their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Wolfe Research initiated coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating for the company. Finally, Mizuho initiated coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.